These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16952530)

  • 21. Adverse effects of excessive ovarian response on the pregnancy rate of in vitro fertilization treatment.
    Ng EH
    Gynecol Endocrinol; 2009 Jan; 25(1):2-7. PubMed ID: 19165656
    [No Abstract]   [Full Text] [Related]  

  • 22. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitrification is a highly efficient method to cryopreserve human embryos in in vitro fertilization patients at high risk of developing ovarian hyperstimulation syndrome.
    Selman H; Brusco GF; Fiorini F; Barnocchi N; Mariani M; El-Danasouri I
    Fertil Steril; 2009 Apr; 91(4 Suppl):1611-3. PubMed ID: 19200960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between follicle number and (multiple) live birth rate after controlled ovarian hyperstimulation and intrauterine insemination.
    Ghesquiere SL; Castelain EG; Spiessens C; Meuleman CL; D'Hooghe TM
    Am J Obstet Gynecol; 2007 Dec; 197(6):589.e1-5. PubMed ID: 18060945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management and obstetric outcome of ovarian hyperstimulation syndrome.
    Zareen N
    J Coll Physicians Surg Pak; 2008 Feb; 18(2):86-90. PubMed ID: 18454892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is VEGF a marker for ovarian response and pregnancy outcome?
    Ferrero S; Belluti A; Anserini P; Remorgida V; Ragni N
    Eur J Obstet Gynecol Reprod Biol; 2005 Aug; 121(2):249; author reply 250. PubMed ID: 16054971
    [No Abstract]   [Full Text] [Related]  

  • 27. [Research on the protocol of limited ovarian stimulation to prevent ovarian hyperstimulation syndrome].
    Zhu YM; Gao HJ; He RH; Huang HF
    Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):740-4. PubMed ID: 17327030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does subfertility explain the risk of poor perinatal outcome after IVF and ovarian hyperstimulation?
    Kapiteijn K; de Bruijn CS; de Boer E; de Craen AJ; Burger CW; van Leeuwen FE; Helmerhorst FM
    Hum Reprod; 2006 Dec; 21(12):3228-34. PubMed ID: 17023490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immediate complications of in vitro fertilization].
    Jokimaa V
    Duodecim; 2006; 122(4):434-40. PubMed ID: 16623098
    [No Abstract]   [Full Text] [Related]  

  • 30. Endometrin for luteal phase support in a randomized, controlled, open-label, prospective in-vitro fertilization trial using a combination of Menopur and Bravelle for controlled ovarian hyperstimulation.
    Doody KJ; Schnell VL; Foulk RA; Miller CE; Kolb BA; Blake EJ; Yankov VI
    Fertil Steril; 2009 Apr; 91(4):1012-7. PubMed ID: 18371963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Follitropin-alpha (Gonal-F) versus follitropin-beta (Puregon) in controlled ovarian hyperstimulation for in vitro fertilization: is there any difference?
    Orvieto R; Nahum R; Rabinson J; Ashkenazi J; Anteby EY; Meltcer S
    Fertil Steril; 2009 Apr; 91(4 Suppl):1522-5. PubMed ID: 18851846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Intra-uterine insemination: ovarian stimulation or not?].
    Belaisch-Allart J; Mayenga JM; Grefenstette I; Chouraqui A; Serkine AM; Abirached F; Plachot M; Kulski O
    Gynecol Obstet Fertil; 2007 Sep; 35(9):871-6. PubMed ID: 17707676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poor responder protocols for in-vitro fertilization: options and results.
    Loutradis D; Vomvolaki E; Drakakis P
    Curr Opin Obstet Gynecol; 2008 Aug; 20(4):374-8. PubMed ID: 18660689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Forty years of IVF.
    Niederberger C; Pellicer A; Cohen J; Gardner DK; Palermo GD; O'Neill CL; Chow S; Rosenwaks Z; Cobo A; Swain JE; Schoolcraft WB; Frydman R; Bishop LA; Aharon D; Gordon C; New E; Decherney A; Tan SL; Paulson RJ; Goldfarb JM; Brännström M; Donnez J; Silber S; Dolmans MM; Simpson JL; Handyside AH; Munné S; Eguizabal C; Montserrat N; Izpisua Belmonte JC; Trounson A; Simon C; Tulandi T; Giudice LC; Norman RJ; Hsueh AJ; Sun Y; Laufer N; Kochman R; Eldar-Geva T; Lunenfeld B; Ezcurra D; D'Hooghe T; Fauser BCJM; Tarlatzis BC; Meldrum DR; Casper RF; Fatemi HM; Devroey P; Galliano D; Wikland M; Sigman M; Schoor RA; Goldstein M; Lipshultz LI; Schlegel PN; Hussein A; Oates RD; Brannigan RE; Ross HE; Pennings G; Klock SC; Brown S; Van Steirteghem A; Rebar RW; LaBarbera AR
    Fertil Steril; 2018 Jul; 110(2):185-324.e5. PubMed ID: 30053940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two cases of cholestasis in the first trimester of pregnancy after ovarian hyperstimulation.
    Zamah AM; El-Sayed YY; Milki AA
    Fertil Steril; 2008 Oct; 90(4):1202.e7-10. PubMed ID: 18929050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment.
    Devroey P; Aboulghar M; Garcia-Velasco J; Griesinger G; Humaidan P; Kolibianakis E; Ledger W; Tomás C; Fauser BC
    Hum Reprod; 2009 Apr; 24(4):764-74. PubMed ID: 19153090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome of 518 salvage oocyte-cryopreservation cycles performed as a routine procedure in an in vitro fertilization program.
    La Sala GB; Nicoli A; Villani MT; Pescarini M; Gallinelli A; Blickstein I
    Fertil Steril; 2006 Nov; 86(5):1423-7. PubMed ID: 17070194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial.
    Serafini P; Yadid I; Motta EL; Alegretti JR; Fioravanti J; Coslovsky M
    Fertil Steril; 2006 Oct; 86(4):830-8. PubMed ID: 16963040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison study of a novel stimulation protocol and the conventional low dose step-up and step-down regimens in patients with polycystic ovary syndrome undergoing in vitro fertilization.
    Koundouros SN
    Fertil Steril; 2008 Sep; 90(3):569-75. PubMed ID: 17880950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repeated pregnancies and live births after in vitro maturation treatment.
    Al-Sunaidi M; Tulandi T; Holzer H; Sylvestre C; Chian RC; Tan SL
    Fertil Steril; 2007 May; 87(5):1212.e9-12. PubMed ID: 17418838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.